Back
Inhibrx Stock Predictions

Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
53
INBX
Inhibrx
Last Price:
25.75
Seasonality Move:
-34.15%
7 Day Trial
ALL ACCESS PASS
$
7

New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register HereInhibrx Stock Forecast
- Over the next 52 weeks, Inhibrx has on average historically fallen by 6.1% based on the past 2 years of stock performance.
- Inhibrx has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Inhibrx Stock Undervalued?
The current Inhibrx [INBX] share price is $25.08. The Score for INBX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Inhibrx Stock Go Up Next Year?
- Over the next 52 weeks, Inhibrx has on average historically fallen by 6.1% based on the past 2 years of stock performance.
Inhibrx Stock Rating
Buy
53
Inhibrx (INBX)
is a Buy
Is Inhibrx overpriced?
- Inhibrx has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Inhibrx Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
inhibrx.com
52-Week Data
52-Week High:
34.72
52-Week Low:
7.67
Prediction Charts
Market Cap:
1.09B
Price in USD:
25.08
Volume:
512.28K
Beta:
0.00
Technical Analysis
SMA50:
26.35
SMA100:
26.19
SMA200:
21.11
52-Wk Change:
-6.49%
Stock Predictions
-
Is Inhibrx stock public?
Yes, Inhibrx is a publicly traded company. -
What is the Inhibrx stock quote today?
The Inhibrx stock price is 25.08 USD today. -
How to buy Inhibrx stock online?
You can buy Inhibrx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-13 | 23.50 | 23.66 | 24.70 | 23.22 |
Jan-17 | 23.52 | 23.28 | 23.83 | 22.80 |
Jan-18 | 23.52 | 22.13 | 23.97 | 21.75 |
Jan-19 | 23.00 | 23.04 | 23.72 | 22.66 |
Jan-20 | 23.44 | 24.18 | 24.30 | 23.00 |
Jan-23 | 24.18 | 25.45 | 25.63 | 23.56 |
Jan-24 | 25.23 | 27.01 | 27.32 | 25.00 |
Jan-25 | 26.65 | 26.59 | 27.29 | 25.70 |
Jan-26 | 26.92 | 26.80 | 26.92 | 26.29 |
Jan-27 | 26.83 | 27.14 | 27.73 | 24.22 |
Jan-30 | 26.72 | 25.13 | 27.49 | 25.03 |
Jan-31 | 25.28 | 25.00 | 26.33 | 24.77 |
Feb-1 | 25.01 | 25.06 | 25.74 | 23.64 |
Feb-2 | 25.49 | 25.08 | 26.16 | 24.84 |
Inhibrx Earnings
Inhibrx Earnings Report: Per Share Inhibrx Earnings Q1 Q2 Q3 and Q4 last year and next year.
Inhibrx Forecast Revenue Growth
Inhibrx Stock Analysis: Historical quarterly revenues per share for Inhibrx and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.
* Inhibrx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.